Pharmacological interventions for schizotypal personality disorder

Saeed Farooq; Birgit A Völlm; Nusrat Husain; Nick Huband; Jutta Stoffers; Simon Gibbon; Conor Duggan; Michael Ferriter; Klaus Lieb

doi:10.1002/14651858.CD009047

Pharmacological interventions for schizotypal personality disorder

Cochrane Database Syst Rev. 2011:(3):CD009047. doi: 10.1002/14651858.CD009047.

Authors

Saeed Farooq¹, Birgit A Völlm², Nusrat Husain³, Nick Huband², Jutta Stoffers⁴, Simon Gibbon⁵, Conor Duggan², Michael Ferriter⁶, Klaus Lieb⁷

Affiliations

¹ Postgraduate Medical Institute, Kyber Medical University, Peshawar, Pakistan.
² Section of Forensic Mental Health, Institute of Mental Health, Nottingham, UK.
³ The University of Manchester and Lancashire Care NHS Trust, Preston, UK.
⁴ Department of Psychiatry and Psychotherapy, University Medical Center Freiburg, Freiburg, Germany.
⁵ St Andrew's Healthcare, Northampton, UK.
⁶ Literature and Evidence Research Unit (LERU), Institute of Mental Health, Nottinghamshire Healthcare NHS Trust, Woodbeck, UK.
⁷ Department of Psychiatry and Psychotherapy, University Medical Center Mainz, Mainz, Germany.

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate the effects of pharmacological interventions for people with Schizotypal Personality Disorder (SzPD).